September 2025 Psychedelic Patent Update: monthly count of psychedelic patent applications, PCT filings, and grant activity in the US

Psychedelic Patent Update tracks published psychedelic patent applications and grants, using Psychedelic Alpha’s tracer for the US IP landscape. For September 2025, the update adds 4 PCTs and 18 US patent applications focused on psychedelics, with new entries tied to companies including Enveric Biosciences, Betterlife Therapeutics, Kuleon, atai Life Sciences, and Clexio Biosciences. The series also incorporates prosecution-status monitoring for 1,300+ US applications, enabling a more detailed view of how applications move through outcomes such as allowed, abandoned, rejected, and examiner response cycles.